Zobrazeno 1 - 10
of 36
pro vyhledávání: '"M Isabel Gonzalez"'
Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.
Autor:
M Carmen Martin, Ana Jimenez, Nuria Ortega, Alba Parrado, Isabel Page, M Isabel Gonzalez, Lydia Blanco-Peris
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0264124 (2022)
BackgroundThe vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study
Externí odkaz:
https://doaj.org/article/0d5950ba509b4a239616c3c005b8cb75
Autor:
Jeffrey L. Cummings, M. Isabel Gonzalez, Martyn C. Pritchard, Patrick C. May, Leticia M. Toledo-Sherman, Glenn A. Harris
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-17 (2023)
Abstract Tauopathies are a group of neurodegenerative disorders characterized by the aggregation of the microtubule-associated protein tau. Aggregates of misfolded tau protein are believed to be implicated in neuronal death, which leads to a range of
Externí odkaz:
https://doaj.org/article/de50d6618bc640deb5ed849724660489
Autor:
M. Carmen Martin, Ana Jimenez, Nuria Ortega, Alba Parrado, Isabel Page, M. Isabel Gonzalez, Lydia Blanco-Peris
Publikováno v:
PloS one. 17(2)
Background The vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c05c89cb2df11eb34eb093f065b65b1
https://pubmed.ncbi.nlm.nih.gov/35202394
https://pubmed.ncbi.nlm.nih.gov/35202394
Autor:
Ana Jiménez, M Isabel Gonzalez, M Carmen Martin, Alba Parrado, Isabel Page, Lydia Blanco-Peris, Nuria Ortega
BackgroundOne of the most questioned issues about SARS-CoV2 immunity is how long does it last. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The answer to this question will determine key iss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8323795d6cdee2ee35f9bfc5569c7e29
https://doi.org/10.1101/2021.06.24.21259079
https://doi.org/10.1101/2021.06.24.21259079
Autor:
Lydia Blanco-Peris, Isabel Page, Ana Jiménez, Nuria Holgado, María Honrubia Pérez, Nuria Ortega, M Isabel Gonzalez, Alba Parrado, M Carmen Martin
Background and objectivesCOVID-19 can either cause death or go unnoticed but antibodies will remain protecting us of SARS-CoV-2 reinfection for an uncertain time and to an uncertain extent. Our aim was to describe seroprevalence evolution from summer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3c1072aef41040f3c215d0f2cdaf438
https://doi.org/10.1101/2021.04.28.21256242
https://doi.org/10.1101/2021.04.28.21256242
Autor:
Anglada, M. Isabel González, Herráiz, Carlos Guijarro, Fernández, Cristina Garmendia, Orbea, Natalia Schoebel, García-Cervigón, Gregorio Palacios, Arias, Javier Marcos, Wolf, Daniel López, Sauce, Beatriz Sánchez
Publikováno v:
In Revista clinica espanola November 2023 223 Supplement 2:S912-S913
Publikováno v:
In BBA - Bioenergetics 2006 1757(11):1476-1484
Autor:
Pamela Kent, Alexander T. McKnight, Tania Bédard, Zul Merali, Hymie Anisman, Nick Andrews, M Isabel Gonzalez, Ben Davis, Martyn Clive Pritchard
Publikováno v:
The Journal of Neuroscience. 26:10387-10396
The effects of PD 176252 [3-(1H-indol-3-yl)-N-[1-(5-methoxy-pyridin-2-yl)-cyclohexylmethyl]-2-methyl-2-[3-(nitro-phenyl)ureido]propionamide], a nonpeptide bombesin (BB) BB1/BB2receptor antagonist, were assessed in rats using several ethologically rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e9e1839c43ec9ee1634982ebc2cd90
https://doi.org/10.1523/jneurosci.1219-06.2006
https://doi.org/10.1523/jneurosci.1219-06.2006
Publikováno v:
Industrial & Engineering Chemistry Research. 45:3243-3247
In this work, a novel process for lactic acid purification based on ion exchange is proposed. It consists of two stages: first, a strong cation resin was used to reduce the broth pH below the pKa of lactic acid (3.86) and remove the cations present i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4af92c78dba1fa58fa93af216f354ee
https://doi.org/10.1021/ie051263a
https://doi.org/10.1021/ie051263a